Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Dabigatran

An oral anticoagulant that directly inhibits thrombin, approved in Europe in 2008. It is given as a prodrug, dabigatran etexilate, which the body converts into the active form. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It was the first of the new oral anticoagulants to get a specific antidote, idarucizumab, an antibody that neutralises it within minutes.

DabigatranGo to the active ingredient →
DabigatranActive ingredientDabigatranCat. No. P-D001-001CAS 211914-51-1
Dabigatran-d3Isotopically labelledDabigatran-d3Cat. No. P-D001-011CAS 1246817-44-6
Dabigatran-d4Isotopically labelledDabigatran-d4Cat. No. P-D001-013CAS 1618637-32-3

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.